Millennium Management’s Legend Biotech LEGN Stock Holding History

Millennium Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,000	Closed	-$497K	–	6272
2025 Q2	$497K	Sell	14,000 -26,000	-65%	-$843K	﹤0.01%	4915
2025 Q1	$1.36M	Buy	+40,000	New	+$1.43M	﹤0.01%	4125
2024 Q3	–	Sell	-80,000	Closed	-$3.54M	–	6309
2024 Q2	$3.54M	Buy	+80,000	New	+$3.69M	﹤0.01%	3045
2023 Q2	–	Sell	-36,200	Closed	-$1.75M	–	6436
2023 Q1	$1.75M	Buy	+36,200	New	+$1.77M	﹤0.01%	3568

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management's LEGN Position: Q1 2026 in Review

Millennium Management increased its Legend Biotech (LEGN) stake by 269% in Q1 2026, buying an estimated $3.96M and bringing the position to 284,911 shares worth $5.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2903.

Millennium Management first reported a position in LEGN in Q2 2020 and has held it in 23 quarters since. The position peaked at $73.5M in Q2 2024. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Millennium Management held 284,911 shares of Legend Biotech worth $5.15M as of Q1 2026.
Millennium Management bought 207,717 Legend Biotech shares in Q1 2026, an estimated $3.96M.
Legend Biotech made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2903 holding.
Millennium Management first reported a position in Legend Biotech in Q2 2020 and has held it in 23 quarters since.
Millennium Management's Legend Biotech position peaked at $73.5M in Q2 2024.
190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.